CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

Hedia Secures Regulatory Approval to Expand Digital Diabetes Care to Pediatric Patients

RegulatoryapprovedPositive
AI Analysis

Summary

Hedia announced regulatory approval expansion of its digital diabetes care platform to pediatric patients through updated MDR certification. The approval unlocks broader insulin regimen support and expanded device connectivity across Hedia's app and partner platforms.

Outcome Details

MDR certification expansion for pediatric diabetes care, broader insulin regimen support, and expanded device connectivity

Importance:6/10
Sentiment:
0.75
digital therapeuticsdiabetespediatricregulatory approvalMDR certificationDenmark

Read the original article

Published by PR Newswire Pharma on September 22, 2026 8:00 AM

Read Original